Jennifer Jacobs, CBS News senior White House reporter, posted on X: “News: Trump announcement on weight loss drugs is scheduled for 11 a.m. tomorrow, sources tell me. The deal, with Eli Lilly (LLY) and Novo Nordisk (NVO) officials, is expected to decrease the drug price to less than $150 a month — in certain cases.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk Stock (NVO) Falls after Medicare Price Deal, Q3 Earnings Miss
- Eli Lilly Stock (LLY) Rises as Competitor Novo Nordisk Cuts Guidance
- Trump Trade: Trump in talks with Lilly, Novo on weight loss drug deal
- Novo Nordisk Reports Strong Sales Growth Amid Restructuring Costs
- Unusually active option classes on open November 5th